Literature DB >> 704649

Brief communication. Generalization of [DAla2]-enkephalinamide but not of substance P to the morphine cue.

R E Chipkin, J M Stewart, D H Morris, T J Crowley.   

Abstract

Rats were trained to discriminate morphine (7.5 mg/kg, IP) from saline in a two bar positively reinforced lever pressing paradigm on a FR4 schedule. Morphine (IP) showed a naloxone reversible dose-related generalization to the training dose. [DAla2]-Methionine enkephalinamide (DAE) at 1 mg/kg and Substance P (SP) at 0.1 and 0.25 mg/kg showed vehicle appropriate responding after IP injection. DAE (5 mg/kg) disrupted responding completely; SP (0.5 and 0.1 mg/kg) disrupted responding in 50% of the rats. The disruption caused by IP injection of DAE was not naloxone reversible. Intraventricular injection of morphine (5 microgram/rat) and DAE (5 microgram/rat) produced generalization to the opiate cue. The effect of DAE was reversed by naloxone (1 mg/kg, SC). SP (500 and 750 ng/rat, IVT) produced saline-like responding; 1 microgram/rat disrupted responding completely. These data demonstrate that morphine and enkephalin, but not Substance P, share similar discriminative properties.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 704649     DOI: 10.1016/0091-3057(78)90023-0

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  3 in total

1.  Morphine acts in the parabrachial nucleus, a pontine viscerosensory relay, to produce discriminative stimulus effects.

Authors:  T V Jaeger; D van der Kooy
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

2.  Morphine-like discriminative stimulus effects of opioid peptides: possible modulatory role of D-Ala2-D-Leu5-enkephalin (DADL) and dynorphin A (1-13).

Authors:  M Ukai; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

3.  Characterization of the discriminative stimulus effects of centrally administered morphine in the rat.

Authors:  K W Locke; S G Holtzman
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.